| Health / Medical Topics |
Ensituximab
A chimeric monoclonal antibody against human colorectal and pancreatic carcinoma-associated antigens (CPAAs) with potential immunomodulating and anti-tumor activities. Anti-CPAA monoclonal antibody NPC-1C binds to CPAAs, which may activate the immune system to exert a cytotoxic T-lymphocyte (CTL) response and an antibody-dependent cellular cytotoxicity (ADCC) response against CPAA-expressing tumor cells. CPAAs, cell surface proteins, are upregulated on colon and pancreatic tumor cells. NPC-1C contains the variable region of the heavy and light chain of murine NPC-1 and linked in-frame to constant regions of a human IgG1 isotype. (NCI Thesaurus)
YOU MAY ALSO LIKE
Ensembl is a joint project between EMBL-EBI and the Sanger Institute to develop a software system which produces and maintains automatic annotation…
A finding about one or more characteristics of adrenal cancer, following the rules of the ENSAT staging v7 classification system.
Stage IV includes: Any T, Any N, M1. Tumor of any size that involves distant organs such as liver, bone or…
Stage III includes: T3/T4, N0/N1, M0. Tumor of any size that has spread to the fat outside the adrenal gland or…
Stage II includes: T2, N0, M0. Tumor greater than 5 cm. The tumor has not invaded surrounding tissues or organs and has…
Stage I includes: T1, N0, M0. Tumor 5 cm or less in greatest dimension. The tumor has not invaded the surrounding…
